ABIONYX Pharma SA (0RAG) Stock Statistics & Valuation Metrics

ABIONYX Pharma SA has a market cap or net worth of €41.58M. The enterprise value is -€206.11K.

ABIONYX Pharma SA has 34,931,010 shares outstanding. The number of shares has decreased by -2.65% in one year.

ABIONYX Pharma SA’s return on equity (ROE) is -0.59 and return on invested capital (ROIC) is -34.21%.

The current PE Ratio of ABIONYX Pharma SA is -9.11. ABIONYX Pharma SA’s PEG ratio is -0.03.

In the last 12 months, ABIONYX Pharma SA had revenue of 4.60M and earned -4.40M in profits. Earnings per share was -0.14.

In the last 12 months, operating cash flow was -3.60M and capital expenditures 0.00, giving a free cash flow of -3.60M billion.

ABIONYX Pharma SA pays an annual dividend of ―, resulting in a dividend yield of ―

ABIONYX Pharma SA upcoming earnings date is Sep 25, 2025, During Market Hours (Confirmed).

ABIONYX Pharma SA as a current ratio of 1.58, with Debt / Equity ratio of 17.75%

In the past 12 months, ABIONYX Pharma SA has paid -1.07M in taxes.

ABIONYX Pharma SA EV to EBITDA ratio is -9.15, with an EV/FCF ratio of -11.01.

ABIONYX Pharma SA has €3.23M in cash and marketable securities with €2.76M in debt, giving a net cash position of -€478.00K billion.

Gross margin is 0.00%, with operating margin of -97.83%, and net profit margin of -95.65%.

The average price target for ABIONYX Pharma SA is ―, which is 11.43% higher than the current price. The consensus rating is ―